Dr. Pierre Kory: COVID-19 pandemic treatment record

Dr. Pierre Kory used an evidence-based early treatment protocol with excellent outcomes. Widespread use of Dr. Kory's protocol would have ended the pandemic much sooner. See all physicians.
c19early.org
COVID-19 TREATMENT RECORD — Dr. Kory vs. Dr. Fauci
RECOMMENDED
TREATMENTS
12 of 12
early recommendations
reduce risk
82 - 98% efficacy
$1.89 / treatment
PREDICTED
OUTCOME
1 month
91 deaths
$13 billion
RECOMMENDED
TREATMENTS
0 of 3
early recommendations
reduce risk
-26% efficacy
$4,060 / treatment
ACTUAL
OUTCOME
3 years
20 million deaths
$20 trillion
Dr. Pierre Kory
CENSORED
Dr. Anthony Fauci
10+ AWARDS
$0 $1,000 $2,000+ -25+% 0% 25% 50% Treatment cost (US$) Efficacy vs. cost: Dr. Kory's protocol vs. USA approved treatments +57 more high-profit drugs PPIs -46% BMS mAbs -36% Darunavir -34% Acetaminophen -28% Cenicriviroc -28% Lufotrelvir Dexamethasone Losartan Sargramostim Cannabidiol Lopinavir/ritonavir Ravulizumab Remdesivir Conv. Plasma Sarilumab Ibuprofen Masks Molnupiravir mutagenic/teratogenic Aspirin Tocilizumab Favipiravir Paxlovid Ratutrelvir Famotidine Vitamin C Sotrovimab Colchicine TMPRSS2 i.. NAC Amubarvimab/r.. Vilobelimab Ensitrelvir Azvudine Budesonide Probiotics HCQ Zinc Antiandro.. Sleep Metformin Vitamin A Melatonin Tixagevimab/c.. Bebtelovimab Nitric Oxide Quercetin H1RAs CPC Vitamin D H. Peroxide Exercise Fluvox. Sunlight Curcumin N. Sativa NaHCO₃ Casirivimab/i.. Bamlanivimab/e.. Ensovibep PVP-I pH+ Diet Regdanvimab Thermotherapy Ivermectin Dr. Kory US official Lowerrisk Higherrisk c19early.org May 2026 Dr. Kory's protocol combines low-cost evidence-basedtreatments with complementary and synergistic effects. Efficacyand cost are favorable compared with official treatments.c19early analyzes over 6,600 studies for 221 treatments.
$0 $1,000 $2,000+ -20+% 0% 25% 50% Treatment cost (US$) Efficacy vs. cost: Dr. Kory's protocol vs. USA approved +57 more high-profit drugs PPIs -46% BMS mAbs -36% Acetaminophen -28% Cenicriviroc -28% Lufotrelvir -22% Dexame.. Losartan Sargramostim CBD Lopinav.. Vit. B9 Ravulizumab Remdesivir C. Plasma Sarilumab Ibuprofen Masks Molnupiravir mutagenic/teratogenic Aspirin Tocilizumab Favipir.. Paxlovid Ratutrelvir Famotidine Vitamin C Sotrovimab Colchicine TMPRSS2 i.. NAC Amubarvimab/r.. Vilobelimab Azvudine Budesonide Probiotics HCQ Zinc Antiandro.. Sleep Metformin Vitamin A Melatonin Tixagev.. Bebtelovimab Nitric Oxide Quercetin H1RAs CPC Vitamin D H. Peroxide Exercise Fluvox. Sunlight Curcumin N. Sativa NaHCO₃ Casirivim.. Bamlan.. Ensovibep PVP-I pH+ Diet Regdanvimab Thermotherapy Ivermectin Dr. Kory US official Lowerrisk Higherrisk c19early.org May 2026 Dr. Kory's protocol combineslow-cost evidence-basedtreatments. c19early analyzes over6,600 studies for 221 treatments.
c19early.org
Dr. Pierre Kory's pandemic record—12 out of 12
Dr. Kory is a critical care specialist that co-founded the FLCCC Alliance, providing evidence-based recommendations for early outpatient treatment. All recommendations were confirmed beneficial in clinical studies. Average treatment cost: $1.89. Predicted combined efficacy: 82%-98%.
CENSORED
Reference Studies Confirmed
beneficial
Outcomes Confidence
ChlorhexidineChlorhexidine I-MASK+ Prevention and e..I-MASK+ Prev..1 5 November 20232 p < 0.0000001
QuercetinQuercetin COVID-19 Management Prot..COVID-19 Man..3 9 January 20224 p = 0.0018
MelatoninMelatonin EVMS Critical Care COVID..EVMS Critica..5 18 May 20216 p < 0.0000001
Povidone-IodinePovidone-Iod.. I-MASK+ Prevention and e..I-MASK+ Prev..1 21 February 20217 p < 0.0000001
FluvoxamineFluvoxamine FLCCC Protocol UpdateFLCCC Protoc..8 21 November 20219 p = 0.00014
FamotidineFamotidine COVID-19 Management Prot..COVID-19 Man..10 29 October 202111 p = 0.00072
ZincZinc EVMS Critical Care COVID..EVMS Critica..5 41 July 202012 p = 0.00000012
Vitamin CVitamin C MATH+ Hospital Treatment..MATH+ Hospit..13 72 September 202014 p < 0.0000001
AspirinAspirin COVID-19 Management Prot..COVID-19 Man..10 79 Positive, small benefit15 p = 0.015
IvermectinIvermectin COVID-19 Management Prot..COVID-19 Man..10 106 August 202016 p < 0.0000001
Vitamin DVitamin D EVMS Critical Care COVID..EVMS Critica..5 137 October 202017 p < 0.0000001
HydroxychloroquineHCQ EVMS Critical Care COVID..EVMS Critica..5 424 March 202018 p < 0.0000001
References